Scotia Capital’s CME Group CME Stock Holding History

Scotia Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.3M	Buy	62,073 +254	+0.4%	+$75.4K	0.08%	150
2025 Q4	$16.9M	Buy	61,819 +4,164	+7%	+$1.13M	0.07%	157
2025 Q3	$15.6M	Buy	57,655 +799	+1%	+$217K	0.07%	161
2025 Q2	$15.7M	Buy	56,856 +3,679	+7%	+$1M	0.07%	152
2025 Q1	$14.1M	Buy	53,177 +1,695	+3%	+$418K	0.08%	150
2024 Q4	$12M	Buy	51,482 +13,454	+35%	+$3.09M	0.06%	161
2024 Q3	$8.39M	Buy	38,028 +11,411	+43%	+$2.36M	0.04%	195
2024 Q2	$5.23M	Buy	26,617 +4,305	+19%	+$889K	0.03%	247
2024 Q1	$4.8M	Buy	22,312 +20,540	+1,159%	+$4.31M	0.03%	258
2023 Q4	$373K	Sell	1,772 -89	-5%	-$19K	﹤0.01%	624
2023 Q3	$373K	Buy	1,861 +66	+4%	+$13.1K	﹤0.01%	602
2023 Q2	$333K	Buy	1,795 +565	+46%	+$104K	﹤0.01%	620
2023 Q1	$236K	Buy	+1,230	New	+$222K	﹤0.01%	683
2022 Q3	–	Sell	-4,502	Closed	-$922K	–	792
2022 Q2	$922K	Buy	4,502 +3,409	+312%	+$723K	0.01%	485
2022 Q1	$260K	Buy	+1,093	New	+$257K	﹤0.01%	762
2021 Q1	–	Sell	-1,252	Closed	-$228K	–	803
2020 Q4	$228K	Sell	1,252 -780	-38%	-$133K	﹤0.01%	684
2020 Q3	$340K	Buy	2,032 +321	+19%	+$54.1K	﹤0.01%	573
2020 Q2	$280K	Buy	+1,711	New	+$307K	﹤0.01%	525
2020 Q1	–	Sell	-1,111	Closed	-$223K	–	659
2019 Q4	$223K	Sell	1,111 -103	-8%	-$21.1K	﹤0.01%	670
2019 Q3	$257K	Sell	1,214 -109	-8%	-$22.8K	﹤0.01%	635
2019 Q2	$257K	Sell	1,323 -276	-17%	-$50.9K	﹤0.01%	633
2019 Q1	$263K	Sell	1,599 -8,911	-85%	-$1.58M	﹤0.01%	601
2018 Q4	$1.98M	Sell	10,510 -8,053	-43%	-$1.49M	0.03%	267
2018 Q3	$3.16M	Buy	18,563 +1,851	+11%	+$312K	0.04%	230
2018 Q2	$2.66M	Buy	16,712 +546	+3%	+$89.2K	0.04%	250
2018 Q1	$2.61M	Buy	16,166 +13,249	+454%	+$2.11M	0.04%	257
2017 Q4	$426K	Buy	2,917 +702	+32%	+$100K	0.01%	560
2017 Q3	$300K	Buy	2,215 +533	+32%	+$67.3K	﹤0.01%	600
2017 Q2	$211K	Buy	+1,682	New	+$201K	﹤0.01%	636
2016 Q4	–	Sell	-40,575	Closed	-$4.24M	–	804
2016 Q3	$4.24M	Hold	40,575	–	–	0.08%	177
2016 Q2	$3.95M	Buy	40,575 +575	+1%	+$54.3K	0.08%	166
2016 Q1	$3.84M	Hold	40,000	–	–	0.08%	145
2015 Q4	$3.62M	Hold	40,000	–	–	0.08%	182
2015 Q3	$3.71M	Hold	40,000	–	–	0.08%	170
2015 Q2	$3.72M	Hold	40,000	–	–	0.07%	190
2015 Q1	$3.79M	Buy	+40,000	New	+$3.71M	0.1%	146
2014 Q4	–	Sell	-40,000	Closed	-$3.2M	–	585
2014 Q3	$3.2M	Sell	40,000 -1,600	-4%	-$121K	0.07%	164
2014 Q2	$2.95M	Buy	41,600 +1,500	+4%	+$106K	0.06%	162
2014 Q1	$2.97M	Sell	40,100 -330	-0.8%	-$24.9K	0.07%	158
2013 Q4	$3.17M	Buy	40,430 +130	+0.3%	+$10.2K	0.08%	155
2013 Q3	$2.98M	Buy	+40,300	New	+$2.97M	0.08%	144

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Scotia Capital's CME Position: Q1 2026 in Review

Scotia Capital increased its CME Group (CME) stake by 0.41% in Q1 2026, buying an estimated $75.4K and bringing the position to 62,073 shares worth $18.3M. The position accounts for 0.08% of the portfolio, ranked #150.

Scotia Capital first reported a position in CME in Q3 2013 and has held it in 41 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Scotia Capital held 62,073 shares of CME Group worth $18.3M as of Q1 2026.
Scotia Capital bought 254 CME Group shares in Q1 2026, an estimated $75.4K.
CME Group made up 0.08% of Scotia Capital's portfolio in Q1 2026, its #150 holding.
Scotia Capital first reported a position in CME Group in Q3 2013 and has held it in 41 quarters since.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.